App Teaches Doctors to Diagnose Skin Cancer
July 21, 2023 updated by: Gustav Gede Nervil, Herlev Hospital
Improving Diagnostic Accuracy in Skin Cancer Diagnostics Using Educational Mobile App: a Randomized Controlled Study
This study aimed to examine if self-paced learning with a novel digital patient-case-based educational platform can increase primary care physicians' diagnostic accuracy of malignant and benign skin lesions on both the level of benign/malignant and the diagnosis level.
Secondarily the study aimed to investigate the time spent in reaching this change in proficiency.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Participants were given a questionnaire and an initial Skin Cancer Multiple Choice-Questionnaire (MCQ) to test their diagnostic skills regardining skin and mole cancer and the most common differential diagnoses.
Participants in the Intervention group was then given access to an educational mobile application (App) for 8 days and asked to diagnose 500 patient cases. The participants did so at their own leisure and time.
After 8 days they were asked to abstain from using the App for another 8 days (wash out period) and were then given a Final Skin Cancer Multiple Choice-Questionnaire (MCQ).
Participants of the control group received no intervention nor education during the 16 days of waiting before they took the final Skin Cancer Multiple Choice-Questionnaire.
Study Type
Interventional
Enrollment (Actual)
3
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Danmark
-
Copenhagen, Danmark, Denmark, 2700
- AISC Research Fascility
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
14 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Primary Care Physician who works in General Practice
Exclusion Criteria:
-
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Intervention
Access to educational mobile application for 8 days, diagnosing 500 digital patient-cases.
|
Educational Mobile Application with a library of digital patient-cases and written learning modules the user can access on 36 common skin lesions, both benign and malignant.
|
|
No Intervention: Control
Control group receiving no intervention, continuing daily practice.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Multiple-Choice Questionnaire (MCQ) Score
Time Frame: Before and immediately after intervention (On average 19 days after enrollment)
|
Participants are given a test before and after the intervention using a skin cancer MCQ test with 12 digital-patient cases.
A higher score means better diagnostic proficiency.
The primary outcome is the change of this score.
|
Before and immediately after intervention (On average 19 days after enrollment)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Diagnostic proficiencies
Time Frame: During the 8 days of access to the educational mobile application.
|
Sensitivity, Specificity and Positive Predictive Value of the participants in the intervention group, calculated on their cases seen in the educational mobile application.
|
During the 8 days of access to the educational mobile application.
|
|
Time spend
Time Frame: During the 8 days of access to the educational mobile application.
|
The Dermloop Learn app tracks how much time each user spends quizzing and reading.
|
During the 8 days of access to the educational mobile application.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 15, 2021
Primary Completion (Actual)
January 15, 2022
Study Completion (Actual)
August 15, 2022
Study Registration Dates
First Submitted
December 5, 2022
First Submitted That Met QC Criteria
December 13, 2022
First Posted (Actual)
December 22, 2022
Study Record Updates
Last Update Posted (Actual)
July 24, 2023
Last Update Submitted That Met QC Criteria
July 21, 2023
Last Verified
July 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- GP-Learn
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
Participant quiz-answer data can be shared upon reasonable request.
IPD Sharing Time Frame
After publication
IPD Sharing Access Criteria
Researchers with interest in skin cancer diagnostics.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.